New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for ...

BostonGene's Chief Scientific Officer, Joe Lennerz, MD, PhD, will participate in the panel session, "Evaluating Digital Pathology and AI in Diagnostics," where he will share insights on the importance ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

A new study by researchers at the Department of Molecular Medicine at SDU sheds light on one of the most severe consequences ...

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline for the use of fibroblast ...

The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.

PathAI, a leading provider of AI-powered technology for pathology, today announced a strategic partnership with Discovery Life Sciences, a leading biospecimens and specialty lab testing company, to ...

ALAFIA’s Aivas supercomputer for healthcare won two innovation awards at this year’s CES event in Las Vegas, Nevada.

Keloids are fibrotic scars that extend beyond the boundaries of the original wound, often causing physical disfigurement and emotional distress.